Stockreport

QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention

Qiagen N.V. Common Shares  (QGEN) 
Last qiagen n.v. common shares earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corporate.qiagen.com/investor-relations
PDF New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settingsFindings show QuantiFERON testing is cost-effecti [Read more]